Related Experiment Video
Updated: Feb 7, 2026

Neuron-Macrophage Co-cultures to Activate Macrophages Secreting Molecular Factors with Neurite Outgrowth Activity
Published on: March 30, 2018
MicroRNA-34a promotes iNOS secretion from pulmonary macrophages in septic suckling rats through activating STAT3
Dong-Liang Cheng1, Hong-Xing Fang2, Yuan Liang3
1Department of Pediatric, Henan Provincial People's Hospital, Zhengzhou, 450000, PR China; Department of Pediatric, People's Hospital of Zhengzhou University, Zhengzhou, 450000, PR China.
Insights
This study reveals microRNA-34a (miR-34a) promotes pediatric sepsis by activating the STAT3 pathway and increasing iNOS production. Inhibiting miR-34a protects against sepsis-induced lung injury, offering a potential therapeutic target.
Area of Science:
- Biomedical Science
- Molecular Biology
- Immunology
Background:
- Pediatric sepsis is a leading global cause of mortality, with high death rates despite advanced treatments.
- Identifying novel therapeutic targets for pediatric sepsis is crucial for improving patient outcomes.
Purpose of the Study:
- To investigate the role of microRNA-34a (miR-34a) in the pathogenesis of pediatric sepsis.
- To explore the potential of targeting miR-34a for sepsis treatment.
Main Methods:
- Investigated miR-34a expression in lipopolysaccharide (LPS)-induced macrophages and U937 cells.
- Assessed the effect of miR-34a inhibition on inducible nitric oxide synthase (iNOS) and STAT3 pathway activation.
- Utilized cecal ligation and puncture (CLP) models in cell lines, lung tissues, and suckling rats.
Main Results:
- miR-34a was upregulated in LPS-induced pulmonary macrophages and U937 cells.
- miR-34a silence decreased iNOS production by inactivating the STAT3 pathway in vitro and in vivo.
- High miR-34a expression increased iNOS and STAT3 levels, while its inhibition protected against lung injury in a rat model.
Conclusions:
- miR-34a promotes iNOS secretion in sepsis via the STAT3 pathway, contributing to lung injury.
- Targeting miR-34a presents a promising therapeutic strategy for pediatric sepsis.
Abstract:
Pediatric sepsis is frequently a fatal condition and a major cause of death globally. The mortality rate of sepsis remains high despite that the advanced therapeutic methods have been carried out. Our research aims to investigate the potentials of miR-34a in the treatment of pediatric sepsis. Results indicated that miR-34a was up-regulated in Lipopolysaccharide (LPS)-induced pulmonary macrophages and U937 cell lines. In addition, miR-34a silence reduced the production of iNOS through inactivating STAT3 pathway in U937 cell lines and cecal ligation and puncture (CLP)-induced lung tissues. Besides, high expression of iNOS and STAT3 in cells transfected with miR-34a mimic further validated it. Furthermore, in vivo experiment demonstrated that miR-34a silence protected CLP-induced suckling rats from lung injury. All in all, our study demonstrated that miR-34a promoted iNOS secretion from pulmonary macrophages in LPS-induced sepsis suckling rats through activating STAT3 pathway. These results provided a possibility to convert miR-34a into clinical application.
More Related Videos
07:44Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
07:15In vivo Macrophage Imaging Using MR Targeted Contrast Agent for Longitudinal Evaluation of Septic Arthritis
Published on: October 20, 2013
Related Concept Videos
MicroRNAs
MicroRNAs
The Eukaryotic Promoter Region
The Eukaryotic Promoter Region
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...
Anaphase Promoting Complex